ARTICLE | Company News
Osaka University (Osaka, Japan) granted Otsuka Pharmaceutical Co. Ltd. (Tokyo, Japan) exclusive, worldwide rights to patents associated with MMG49, a CAR T cell therapy that targets the active conformer of integrin β(7). ...
BCIQ Target Profiles